What is ARAY's market cap?

$17.81M, based on the Nov 4 close of $0.15.

Does Accuray Incorporated pay a dividend?

No regular cash dividend has been paid in the last year.

How much of ARAY is sold short?

5.0M shares, 5.9% of float, as of Oct 15, 2026.

What sector is ARAY in?

Healthcare, in the Surgical Instruments industry.

NASDAQ · ARAYHealthcareSurgical Instruments

Accuray Incorporated (ARAY)

$0.1491+3.97%

Close Nov 4, 2026 · split-adjusted

Nov 4, 2026$0.15▼ 89.20% in range

Nov 4, 2025Low $0.12 · High $1.45Nov 4, 2026

What changed · written from our data

As of Nov 4, 2026

Accuray Incorporated closed at $0.15 on Nov 4, up 3.97%, 89.7% below its 52-week closing high. Volume of 4.6M shares was 2.38× its 20-day average (well above normal).

Split-adjusted performance: -43.0% over one month, -68.7% over six months, -89.3% over one year.

In the quarter ended Jun 30, 2026, revenue was $100.92M, down 20.9% from a year earlier, with a net margin of -1.9%.

Short interest was 5.0M shares at the Oct 15 settlement, down 31.7% from the prior report (5.9% of float, 2.2 days to cover).

Market cap$17.8M119.4M shares

Revenue · quarter$100.9M−20.9% YoY

Diluted EPS$-0.02−300.0% YoY

P/E · TTM—P/S 0.0×

Net margin-1.9%Gross 34.8%

Dividend yieldNone

52-week range0.12 – 1.45−89.7% from high

Volume4.6M2.38× 20-day avg

Volatility · 60d106.9%Annualised

Short % of float5.9%2.2 days to cover

Net cash-$107.2MCash $40.6M

Next earnings—Not scheduled

Split-adjusted performance

1W +13.8%1M −43.0%3M −47.3%6M −68.7%YTD −81.9%1Y −89.3%3Y −94.3%5Y −96.6%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum14

Revenue growth7

Net margin58

Value (low P/E)—

Size24

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →

Shares short5.0M−31.7% vs prior

Days to cover2.2Settled Oct 15

% of float5.9%

Short vol. 10d50.7%of daily volume

Closest peers by size in Surgical Instruments

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
ARAYAccuray Incorporated	$0.1491	+3.97%	−68.7%	−20.9%	−1.9%	—	$17.8M
RVPRetractable Technologies	$0.5660	+0.71%	−18.3%	−31.1%	38.5%	—	$16.9M	Compare
PMIPicard Medical	$7.19	−7.58%	−38.0%	—	−191.6%	—	$16.8M	Compare
MODDModular Medical	$1.67	−5.65%	−57.3%	—	—	—	$15.9M	Compare
CTSOCytosorbents	$4.56	+0.44%	−60.0%	+0.2%	−45.9%	—	$14.4M	Compare
PAVMPAVmed	$1.66	−8.79%	−76.3%	+450.0%	−16603.0%	—	$13.3M	Compare
BEATHeartbeam	$0.4241	−1.40%	−50.5%	—	—	—	$23.9M	Compare
GUTSFractyl Health	$0.9725	+8.27%	−89.0%	—	—	—	$12.9M	Compare
SINTSiNtx Technologies	$1.66	−3.49%	−30.8%	+199.3%	−803.5%	—	$12.5M	Compare

News about Accuray Incorporated

All news →

No recent articles focused on Accuray Incorporated.

Quick answers

What does Accuray Incorporated do?: Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body.
What is ARAY's market cap?: $17.81M, based on the Nov 4 close of $0.15.
Does Accuray Incorporated pay a dividend?: No regular cash dividend has been paid in the last year.
How much of ARAY is sold short?: 5.0M shares, 5.9% of float, as of Oct 15, 2026.
What sector is ARAY in?: Healthcare, in the Surgical Instruments industry.

About Accuray Incorporated

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention. The company has one operating segment which develops, manufactures and markets proprietary medical devices used in radiation therapy for the treatment of cancer patients.

HQ: Madison, WI809 employeesListed Feb 8, 2007accuray.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology